mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.0001 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0001 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0001 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |